APP and Alzheimer disease: Thus, Mn enhancement of microglia activation cannot only lesion the brain neurons directly via the established cytokine-based mechanisms (Minter et al., 2016; Hansen et al., 2018; Nichols et al., 2019; Simon et al., 2019) but also by increasing APP expression and amyloidogenic APP processing, contributing to AD pathogenesis and neurodegeneration.